|
|
|
|
| MMC243a | 多肿瘤(三种)组织芯片，附病理分级、TNM和临床分期，24例/24点，替代MC243 | | 点 数 | 24 | 例 数 | 24 | | 行 数 | 3 | 列 数 | 8 | | 点直径(mm) | 2.0 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
Lun -Lung Bre -Breast Sto -Stomach |
Malignant (*) Malignant (I) Malignant (IB) Malignant (II) Malignant (IIA) Malignant (IIB) Malignant (IIIA) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 75 | M | Stomach | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant | N |
| A2 | 2 | 70 | F | Stomach | Adenocarcinoma | 1 | T3N0M0 | II | Malignant | N |
| A3 | 3 | 61 | M | Stomach | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant | N |
| A4 | 4 | 53 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | II | Malignant | N |
| A5 | 5 | 69 | F | Stomach | Adenocarcinoma | 3 | T3N0M0 | II | Malignant | N |
| A6 | 6 | 60 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | II | Malignant | N |
| A7 | 7 | 82 | F | Stomach | Adenocarcinoma | 3 | T3N0M0 | II | Malignant | N |
| A8 | 8 | 63 | M | Stomach | Adenocarcinoma | 3 | T2N1M0 | II | Malignant | N |
| B1 | 9 | 48 | F | Breast | Invasive ductal carcinoma | 2 | T1N0M0 | I | Malignant | N |
| B2 | 10 | 65 | F | Breast | Invasive ductal carcinoma | 1 | T2N1M0 | IIB | Malignant | N |
| B3 | 11 | 42 | F | Breast | Invasive ductal carcinoma | 1 | T2N0M0 | IIA | Malignant | N |
| B4 | 12 | 45 | F | Breast | Invasive ductal carcinoma | 2 | T2N0M0 | IIA | Malignant | N |
| B5 | 13 | 72 | F | Breast | Invasive ductal carcinoma | 2 | T2N0M0 | IIA | Malignant | N |
| B6 | 14 | 52 | F | Breast | Invasive ductal carcinoma | 2 | T3N0M0 | IIB | Malignant | N |
| B7 | 15 | 49 | F | Breast | Invasive ductal carcinoma | 3 | T2N0M0 | IIA | Malignant | N |
| B8 | 16 | 45 | F | Breast | Invasive ductal carcinoma | 3 | T2N0M0 | IIA | Malignant | N |
| C1 | 17 | 66 | M | Lung | Squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant | N |
| C2 | 18 | 55 | M | Lung | Squamous cell carcinoma | 1 | T2N0M0 | IB | Malignant | N |
| C3 | 19 | 61 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant | N |
| C4 | 20 | 65 | M | Lung | Adenocarcinoma | 1 | * | * | Malignant | N |
| C5 | 21 | 36 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | II | Malignant | N |
| C6 | 22 | 30 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | N |
| C7 | 23 | 46 | M | Lung | Adenocarcinoma (lung tissue) | * | T2N0M0 | IB | Malignant | N |
| C8 | 24 | 53 | F | Lung | Papillary adenocarcinoma | 1 | T2N1M0 | IIB | Malignant | N | | Tissue Marker |
|
|
